Scientists at the Johns Hopkins Kimmel Cancer Center have created a new kind of blood test that may help detect cancer at an early stage. The test works by looking at how random or unstable certain ...

Tumor marker blood tests may help inform various aspects of cancer care, including diagnosis, staging, treatment planning, and outlook. However, they’re often not the only diagnostic tests used. If ...

National Institutes of Health (NIH)-supported investigators have developed a blood test to find pancreatic ductal ...

Cancer screening is at a turning point. For decades, most tests focused on one form of the disease — like mammograms for breast cancer or colonoscopies for colorectal cancer — but new advances have ...

A personalized blood test known as a circulating tumor DNA (ctDNA) test—which detects tiny fragments of cancer DNA circulating in the bloodstream—may help identify liver cancer recurrence earlier in ...

The new blood-based assay PAC-MANN-1 (protease activity–based cancer marker using magnetic nanosensor-1) identified pancreatic ductal adenocarcinoma (PDAC) across all stages with high specificity and ...

A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people. The results were presented at the 2025 American Society of Clinical ...

Cancer is the second leading cause of death worldwide. It accounts for an estimated 9.6 million deaths, or 1 in 6 deaths, in 2018, according to the World Health Organization (WHO). The numbers are ...

However, tumor marker tests aren’t the only tools they’ll use in cancer care. Other testing techniques will help provide a more comprehensive look at your type of cancer. Regular cells may produce ...